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Background
Persistent gliosis, if present in the hydrocephalic brain,
has the potential to alter the biomechanical properties of
the brain, impair cerebral perfusion, impede neuronal
regeneration and affect plasticity. The purpose of this
study was to determine the ability of minocycline, a spe-
cific inhibitor of glial reactivity, to reduce glial scar forma-
tion in the H-Tx rat model of congenital hydrocephalus.
Materials and methods
Minocycline (45 mg/kg/day i.p. in 5% sucrose) was
administered to 6 hydrocephalic and 5 non-hydro-
cephalic animals, from postnatal days 15 through 21.
These treated animals were compared to age-matched 21
day untreated control and hydrocephalic littermates (n =
5 each). Cortical tissue was paraffin embedded and
selected regions subjected to immunohistochemistry
using Ionized calcium binding adaptor molecule 1(IBA1)
to label microglia and Glial Fibrillary Acidic Protein
(GFAP) to label astrocytes. Tissue sections were then ana-
lyzed using light microscopy and non-biased stereology to
quantify the density of these specific glial cells.
Results
Minocycline was effective in reducing the relative amount
of both microglia and astrocytes present in the treated
hydrocephalic animals compared to untreated animals.
Hydrocephalic animals receiving minocycline exhibited a
significant (p < 0.05) reduction in astrocyte density by
2.93 fold and a significant (p < 0.05) reduction of micro-
glial density of 3.41 fold. Although minocycline treatment
reduced the overall concentration of these glial cells com-
pared to the untreated hydrocephalic animals, the treated
hydrocephalic animals still possessed a significantly
higher (p < 0.05) density of astrocytes (1.76 fold) and
microglia (1.51 fold) than the untreated control animals.
Minocycline also increased cortical thickness in the
treated hydrocephalic group. The anterior portion of the
occipital cortex in the treated hydrocephalic animals pos-
sessed a significantly (p < 0.05) thicker cortex compared
to the untreated hydrocephalic animals when measured at
the dorsal (1.97 fold), lateral (2.10 fold) and temporal
(2.88 fold) regions of the cerebral hemisphere.
Conclusion
Overall, our data suggest that relatively short-term mino-
cycline treatment is effective in reducing the astrogliosis
and microgliosis that accompanies ventriculomegaly
while also increasing cortical thickness. The administra-
tion of this drug may therefore provide an added benefit
when used as a supplement to ventricular shunting for the
long-term control of gliosis.
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